Any views and opinions expressed are those of the author (s) and/or participants and do not necessarily reflect the views, policy, or position of Physician’s Weekly, their employees, and affiliates.

The meta-analysis identified a significant association between treatment with semaglutide and risk for NAION (OR, 3.92; 95% ...